This research tackles antibiotic resistance by developing nano-scale microfluidic cultures that isolate and study previously unculturable bacteria. By screening rare microbes and directly testing their antimicrobial activity, the platform accelerates discovery of new antibiotics, offering a powerful tool against drug-resistant superbugs.

A $2 portable HIV test chip that combines PCR-level sensitivity with home-test simplicity. Using magnetic microparticles, custom probes, and automated processing, it delivers rapid color-change results from a single drop of blood. The system could diagnose HIV and other viruses quickly, affordably, and anywhere.

This research develops one of the most advanced human-engineered brain models to better study Alzheimer’s disease and test treatments. Using microfluidic chips containing all key brain cell types, blood-vessel systems, and Alzheimer’s-model neurons, the project enables efficient drug testing, personalised disease modelling, and the possibility of replacing animal testing in the search for a cure.